New imaging tool for brain tumor surgery
Treatments studied
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a new imaging tool that helps surgeons look at brain tissue during your operation, so they can make faster and more accurate diagnoses. It may help guide the surgery to remove as much tumor as possible while preserving healthy brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a suspected brain tumor and be scheduled for surgery to remove it.
- You must be able to sign a consent form to participate.
- Your tumor must be at least 1 cm (about the size of a pea) in size for reliable imaging.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special imaging tool that helps surgeons see brain tumors more clearly during surgery, so they can remove as much tumor as possible while protecting healthy tissue. It is designed for people already having surgery to remove a brain tumor.
This study tests a special microscope that helps surgeons see brain tumors more clearly during surgery. The goal is to see if it can help remove more of the tumor safely.
This trial uses a special dye called indocyanine green (ICG) during surgery to make giant cell bone tumors glow, helping doctors remove them more accurately. It may lead to better surgical outcomes for people with this tumor type.
This early (Phase 1) study tests whether a glowing dye called indocyanine green helps surgeons better see nervous system tumor tissue during an operation, with the goal of lowering the chance of tumor coming back locally. It’s for adults whose tumor is expected to be removable and at risk for local recurrence.
This trial tests a dye called indocyanine green (ICG) that makes cancer cells glow under a special camera during surgery. It may help doctors remove more cancer and leave healthy tissue alone.
This early-stage study tests an intraoperative imaging approach called “TumorGlow” to help surgeons better identify tumor tissue during surgery. It may help improve the completeness of tumor removal and reduce the chance of recurrence in certain patients.
Hear when a new Indocyanine Green (ICG) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.